Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$1.17M Sell
9,100
-52,200
-85% -$6.85M ﹤0.01% 3434
2014
Q2
$8.14M Buy
61,300
+58,500
+2,089% +$7.67M 0.01% 1533
2014
Q1
$367K Sell
2,800
-1,600
-36% -$207K ﹤0.01% 4562
2013
Q4
$572K Buy
4,400
+2,500
+132% +$312K ﹤0.01% 4177
2013
Q3
$228K Sell
1,900
-2,800
-60% -$332K ﹤0.01% 5032
2013
Q2
$541K Buy
+4,700
New +$535K ﹤0.01% 4023

Other funds holding PX

UBS's PX Position: Q3 2014 in Review

UBS increased its Praxair Inc (PX) stake by 6.3% in Q3 2014, buying an estimated $2.3M and bringing the position to 297,798 shares worth $38.4M. The position accounts for 0.03% of the portfolio, ranked #615.

UBS first reported a position in PX in Q2 2013 and has held it in 6 quarters since. The position peaked at $40.4M in Q3 2013. 886 funds tracked by Wall St. Rank hold PX as of Q3 2014.

  • UBS held 297,798 shares of Praxair Inc worth $38.4M as of Q3 2014.
  • UBS bought 17,559 Praxair Inc shares in Q3 2014, an estimated $2.3M.
  • Praxair Inc made up 0.03% of UBS's portfolio in Q3 2014, its #615 holding.
  • UBS first reported a position in Praxair Inc in Q2 2013 and has held it in 6 quarters since.
  • UBS's Praxair Inc position peaked at $40.4M in Q3 2013.
  • 886 funds tracked by Wall St. Rank held Praxair Inc as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.